4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-014167
CHAIRMAN & CEO sold 2,349 shares at $27.02 ($63,470)
- CHAIRMAN & CEO acquired 2,349 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanj K CHAIRMAN & CEO | 2025-05-20 | Option exercise 10b5-1 | +2,349 | $1.59 | $3,735 | 99,023 | D |
| Patel Sanj K CHAIRMAN & CEO | 2025-05-20 | Sale 10b5-1 | −2,349 | $27.02 | $63,470 | 96,674 | D |
| Derivatives | |||||||
| Patel Sanj K CHAIRMAN & CEO | 2025-05-20 | Option exercise · Share Option 10b5-1 | −2,349 | 86,270 | D | ||
| Open-market sales · 2,349 sh · avg $27.02 · $63,470 | |||||||
Loading xslF345X05/form4-05222025_080524.xml…